Question 1

What is the catalog number for MAN1A2 Knockout HT29 Polyclonal Cells?

Accepted Answer

The catalog number for MAN1A2 Knockout HT29 Polyclonal Cells is ARG13895.

Question 2

What sizes are available for MAN1A2 Knockout HT29 Polyclonal Cells?

Accepted Answer

MAN1A2 Knockout HT29 Polyclonal Cells is available in the following size(s): 1 Million.

Question 3

Is MAN1A2 Knockout HT29 Polyclonal Cells in stock?

Accepted Answer

MAN1A2 Knockout HT29 Polyclonal Cells is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for MAN1A2 Knockout HT29 Polyclonal Cells?

Accepted Answer

MAN1A2 Knockout HT29 Polyclonal Cells is requires dry ice shipping.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

MAN1A2 Knockout HT29 Polyclonal Cells

Product Specifications

Type

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human ZHX1-C8orf76 activation kit by CRISPRa

Anti-PIP (PIP1;1, PIP1;2, PIP1;3, PIP1;4, PIP1;5) aquaporins, DyLight® 488 conjugated (40 µg)

Oxytocin-neurophysin 1 / OXT Recombinant Chimeric Antibody Antibody

CARS2 (C-term) Rabbit Polyclonal Antibody

PE/Elab Fluor® 594 Anti-Human CD38 Antibody[AT13/5]

PE/Elab Fluor® 594 Anti-Human CD38 Antibody[AT13/5]